These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 3056819

  • 21. Does taurine bind to the insulin binding site of the insulin receptor?
    Kulakowski EC, Maturo J.
    Prog Clin Biol Res; 1990; 351():95-102. PubMed ID: 2236159
    [No Abstract] [Full Text] [Related]

  • 22. Characteristics of the human lymphocyte insulin receptor.
    Gavin JR, Gorden P, Roth J, Archer JA, Buell DN.
    J Biol Chem; 1973 Mar 25; 248(6):2202-7. PubMed ID: 4347860
    [No Abstract] [Full Text] [Related]

  • 23. Human insulin production from a novel mini-proinsulin which has high receptor-binding activity.
    Chang SG, Kim DY, Choi KD, Shin JM, Shin HC.
    Biochem J; 1998 Feb 01; 329 ( Pt 3)(Pt 3):631-5. PubMed ID: 9445392
    [Abstract] [Full Text] [Related]

  • 24. The human lymphocyte: a model for the study of insulin-receptor interaction.
    Olefsky J, Reaven GM.
    J Clin Endocrinol Metab; 1974 Apr 01; 38(4):554-60. PubMed ID: 4362393
    [No Abstract] [Full Text] [Related]

  • 25. Effect of down-regulation of insulin receptors on receptor-antibody binding.
    Blackard WG, Sherrod J, Ludeman C.
    Endocrinology; 1981 Feb 01; 108(2):478-83. PubMed ID: 7004857
    [Abstract] [Full Text] [Related]

  • 26. The (ProB27, ThrB28) human insulin analogue is more potent and more rapidly absorbed from subcutis than human insulin.
    Clausen R, Jørgensen TG, Jørgensen KH, Johnsen AH, Led JJ, Josefsen K.
    Eur J Endocrinol; 2002 Aug 01; 147(2):227-33. PubMed ID: 12153745
    [Abstract] [Full Text] [Related]

  • 27. Insulin binding to isolated human adipocytes.
    Olefsky JM, Jen P, Reaven GM, Alto P.
    Diabetes; 1974 Jul 01; 23(7):565-71. PubMed ID: 4366488
    [No Abstract] [Full Text] [Related]

  • 28. Properties of the insulin receptor of isolated fat cell membranes.
    Cuatrecasas P.
    J Biol Chem; 1971 Dec 10; 246(23):7265-74. PubMed ID: 5167021
    [No Abstract] [Full Text] [Related]

  • 29. Conversion of (125I)insulin and (125I)proinsulin into high molecular weight forms in vivo.
    Antoniades HN, Stathakos D, Simon JD.
    Endocrinology; 1974 Dec 10; 95(6):1543-53. PubMed ID: 4434902
    [No Abstract] [Full Text] [Related]

  • 30. Receptor binding properties of human insulin (recombinant DNA) and human proinsulin and their interaction at the receptor site.
    Prager R, Schernthaner G.
    Diabetes Care; 1982 Dec 10; 5 Suppl 2():104-6. PubMed ID: 6765518
    [Abstract] [Full Text] [Related]

  • 31. Disposition of 131I proinsulin in the rat. Comparisons with 131 I insulin.
    Izzo JL, Roncone AM, Helton DL, Izzo MJ.
    Diabetes; 1978 Apr 10; 27(4):400-10. PubMed ID: 640245
    [No Abstract] [Full Text] [Related]

  • 32. Insulin-induced loss of the insulin receptor in IM-9 lymphocytes. A biological process mediated through the insulin receptor.
    Kosmakos FC, Roth J.
    J Biol Chem; 1980 Oct 25; 255(20):9860-9. PubMed ID: 7000764
    [Abstract] [Full Text] [Related]

  • 33. Binding of 125I-human growth hormone to specific receptors in human cultured lymphocytes. Characterization of the interaction and a sensitive radioreceptor assay.
    Lesniak MA, Gorden P, Roth J, Gavin JR.
    J Biol Chem; 1974 Mar 25; 249(6):1661-7. PubMed ID: 4361817
    [No Abstract] [Full Text] [Related]

  • 34. Receptor-binding assay of chemically modified insulins. Comparison with in vitro and in vivo bioassays.
    Freychet P, Brandenburg D, Wollmer A.
    Diabetologia; 1974 Feb 25; 10(1):1-5. PubMed ID: 4365215
    [No Abstract] [Full Text] [Related]

  • 35. Comparison of solution structural flexibility and zinc binding domains for insulin, proinsulin, and miniproinsulin.
    Kaarsholm NC, Ko HC, Dunn MF.
    Biochemistry; 1989 May 16; 28(10):4427-35. PubMed ID: 2669954
    [Abstract] [Full Text] [Related]

  • 36. Reduction and reoxidation of bovine proinsulin. Effect of pH, zinc ions, temperature and concentration.
    Markussen J, Heding LG.
    Int J Pept Protein Res; 1974 May 16; 6(4):245-52. PubMed ID: 4426736
    [No Abstract] [Full Text] [Related]

  • 37. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.
    Gavin JR, Roth J, Neville DM, de Meyts P, Buell DN.
    Proc Natl Acad Sci U S A; 1974 Jan 16; 71(1):84-8. PubMed ID: 4359334
    [Abstract] [Full Text] [Related]

  • 38. Specific binding of nonsupressible insulinlike activity to chicken embryo fibroblasts and to a solubilized fibroblast receptor.
    Zapf J, Mäder M, Waldvogel M, Schalch DS, Froesch ER.
    Arch Biochem Biophys; 1975 Jun 16; 168(2):630-7. PubMed ID: 237486
    [No Abstract] [Full Text] [Related]

  • 39. Insulin, S-sulphonate A and S-sulphonate B-chain receptor binding to human cultured lymphocytes.
    Kobayashi M, Meek JC.
    Diabetologia; 1977 May 16; 13(3):251-5. PubMed ID: 559608
    [Abstract] [Full Text] [Related]

  • 40. Biosynthetic human proinsulin. Review of chemistry, in vitro and in vivo receptor binding, animal and human pharmacology studies, and clinical trial experience.
    Galloway JA, Hooper SA, Spradlin CT, Howey DC, Frank BH, Bowsher RR, Anderson JH.
    Diabetes Care; 1992 May 16; 15(5):666-92. PubMed ID: 1516487
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.